Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 13, Issue 3, 2014, Pages 264-270

  Chen, Xi ^a   Li, Bo ^a   He, Wei ^a   Wei, Yong Gang ^a   Du, Zheng Gui ^a   Jiang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Complication; Extended hemihepatectomy; Hepatocellular carcinoma; Mesohepatectomy; Survival

Indexed keywords

BILIRUBIN; OXIDIZED REGENERATED CELLULOSE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISSECTOR; FEMALE; HEMIHEPATECTOMY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MESOHEPATECTOMY; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SURGICAL INFECTION; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BILIRUBIN; BIOMARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OPERATIVE TIME; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904035976     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(14)60253-8     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995;130:198-203.
3. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002;47:389-399.
4. al-Hadeedi S, Choi TK, Wong J. Extended hepatectomy for hepatocellular carcinoma. Br J Surg 1990;77:1247-1250.
5. Blumgart LH, Baer HU, Czerniak A, Zimmermann A, Dennison AR. Extended left hepatectomy: technical aspects of an evolving procedure. Br J Surg 1993;80:903-906.
6. MacIntosh EL, Minuk GY. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 1992;174:245-254.
7. Wanebo HJ, Chu QD, Avradopoulos KA, Vezeridis MP. Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery 1996;119:361-371.
8. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994;115:674-677.
9. Povoski SP, Fong Y, Blumgart LH. Extended left hepatectomy. World J Surg 1999;23:1289-1293.
10. McBride CM, Wallace S. Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg 1972;105:289-296.
11. Scudamore CH, Buczkowski AK, Shayan H, Ho SG, Legiehn GM, Chung SW, et al. Mesohepatectomy. Am J Surg 2000; 179:356-360.
12. Qiu J, Wu H, Bai Y, Xu Y, Zhou J, Yuan H, et al. Mesohepatectomy for centrally located liver tumours. Br J Surg 2013;100:1620-1626.
13. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, 5th ed. Tokyo: Kanehara; 2009.
14. Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012;18: 2995-3003.
15. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The 50-50 criteria on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-829.
16. Takasaki K. Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation. J Hepatobiliary Pancreat Surg 1998;5:286-291.
17. Mehrabi A, Mood ZA, Roshanaei N, Fonouni H, Müller SA, Schmied BM, et al. Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg 2008;207: 499-509.
18. Vauthey JN, Baer HU, Guastella T, Blumgart LH. Comparison of outcome between extended and nonextended liver resections for neoplasms. Surgery 1993;114:968-975.
19. Chiappa A, Zbar AP, Audisio RA, Leone BE, Biella F, Staudacher C. Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol 2000;26:387-392.
20. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999;229:210-215.
21. Chen XP, Qiu FZ, Lau WY, Zhang BX, Chen YF, Zhang WG, et al. Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients. Int J Colorectal Dis 2008;23:543-546.
22. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-681.
23. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237:686-693.
24. Elias D, Cavalcanti A, de Baere T, Roche A, Lasser P. Longterm oncological results of hepatectomy performed after selective portal embolization. Ann Chir 1999;53:559-564.
25. Giuliante F, Nuzzo G, Ardito F, Vellone M, De Cosmo G, Giovannini I. Extraparenchymal control of hepatic veins during mesohepatectomy. J Am Coll Surg 2008;206:496-502.
26. Kim KH, Kim HS, Lee YJ, Park KM, Hwang S, Ahn CS, et al. Clinical analysis of right anterior segmentectomy for hepatic malignancy. Hepatogastroenterology 2006;53:836-839.
27. Jamieson GG, Corbel L, Campion JP, Launois B. Major liver resection without a blood transfusion: is it a realistic objective? Surgery 1992;112:32-36.
28. Rahbari NN, Koch M, Zimmermann JB, Elbers H, Bruckner T, Contin P, et al. Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 2011;253:1102-1110.
29. Chen XP, Zhang ZW, Zhang BX, Chen YF, Huang ZY, Zhang WG, et al. Modified technique of hepatic vascular exclusion: effect on blood loss during complex mesohepatectomy in hepatocellular carcinoma patients with cirrhosis. Langenbecks Arch Surg 2006;391:209-215.
30. Stratopoulos C, Soonawalla Z, Brockmann J, Hoffmann K, Friend PJ. Central hepatectomy: the golden mean for treating central liver tumors? Surg Oncol 2007;16:99-106.
31. Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, et al. Bile leakage after hepatic resection. Ann Surg 2001;233:45-50.
32. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004;135:404-410.
33. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995;117:677-681.
34. Chouillard E, Cherqui D, Tayar C, Brunetti F, Fagniez PL. Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann Surg 2003;238:29-34.
35. Chen XP, Hu DY, Zhang ZW, Zhang BX, Chen YF, Zhang WG, et al. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 2007;24:208-213.
36. Okano A, Hajiro K, Takakuwa H, Nishio A, Matsusue S, Sano A, et al. Diffuse intrahepatic recurrence after resection of hepatocellular carcinoma. Hepatogastroenterology 2000;47: 1356-1359.